Latest News
|
21 March 2013
0 Likes 
The EU and US regulatory approvals process by which pharmaceutical products used to treat chronic conditions get approved is lacking in rigor, argues a new paper published in the Public Library of
Read More...
News
Latest News
|
30 August 2012
0 Likes
The United Kingdom health minister said local NationalHealth Service (NHS) organizations must provide a list of drugs approved by theNational Institute for Clinical Excellence (NICE), according to a
Read More...
Regulatory Update
|
28 August 2012
0 Likes
Australia’s Therapeutic Goods Administration (TGA) has released revised guidance on the evidence required to support indications made for over-the-counter (OTC)medicines.Therevised version now permits
Read More...
Latest News
|
6 August 2012
0 Likes
Abbreviated new drug applications—also known as generic drug applications or 505(j) applications—have saved US citizens more than a trillion dollars in the past decade, says a new report out from the
Read More...
Regulatory Update
|
30 July 2012
0 Likes
Brazilian consumers will not be able to purchase over-the-counter drug products at pharmacies according to new rules published 17 July 2012 by Brazilian health regulator Anvisa.Under the new rules,
Read More...
Regulatory Update
|
7 May 2012
0 Likes
Brazil’s national regulatory agency, Anvisa, announced a tool for answering questions about the prices of drugs and devices providing greater transparency in public and private reimbursement of the
Read More...
Latest News
|
16 March 2012
0 Likes
Many cancer patients taking oncology drugs might see the beneficial effects of their medication fail to materialize if they are taking other medications, says a new study by Medco Health Solutions
Read More...
Latest News
|
14 March 2012
0 Likes
Canadian is increasingly facing a problem widespread in the US: drug shortages. The issue, described as ‘endemic’ by The Globe and Mail, has become particularly acute in recent days after a fire at a
Read More...
Latest News
|
13 March 2012
0 Likes
An US Food and Drug Administration (FDA) Advisory Committee Panel recommended clinical trials testing anti-nerve growth factor inhibitors (anti-NGF inhibitors) be allowed to continue, with certain
Read More...
Latest News
|
12 March 2012
0 Likes
The Generic Pharmaceutical Association (GPhA) is planning to launch a private, third-party program to track and share information about drug shortages, according to the American Medical
Read More...